Hypergammalglobulinemia, unspecified

D3_HYPERGAMMAGLONAS

immune system disease: A disorder resulting from an abnormality in the immune system.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D89.2
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D89.2
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

23

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

23

diagram downward connector

Check minimum number of events None

23

diagram downward connector

Include endpoints None

23

diagram downward connector
D3_HYPERGAMMAGLONAS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D89
Name in latin Hypergammaglobulinaemia non specificata

Similar endpoints

List of similar endpoints to Hypergammalglobulinemia, unspecified based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 23 8 15
Unadjusted prevalence (%) 0.01 0.00 0.01
Mean age at first event (years) 63.49 54.27 68.41

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: D3_HYPERGAMMAGLONAS – Hypergammalglobulinemia, unspecified
GWS hits:

Survival analyses between endpoints

Plot

before Hypergammalglobulinemia, unspecified
after Hypergammalglobulinemia, unspecified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hypergammalglobulinemia, unspecified